KPIs & Operating Metrics(New)
Breakdown Of AssetsContractual ObligationCost Of RevenueCustomer Additions AnnualCustomers Count AnnualDeferred RevenueEmployee StatisticsGross Margin %Gross ProfitIncome (Loss) Before Income Taxes By RegionLong Lived AssetsNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNo. Of Genes ShippedNo. Of Genes Shipped AnnualNo. Of Orders TotalNo. Of Orders Total AnnualNo. Of ShipmentsOpex As A % Of Total Revenue %OPEX SegregationOrder BreakdownProperty And Equipment, Net BreakdownRevenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By IndustryRevenue By Industry %Revenue By Industry AnnualRevenue By Industry Annual %Revenue By ProductRevenue By Product %Revenue By Product AnnualRevenue By Product Annual %Revenue Mix From Repeat Customers %Shipped ProductsValue Of Orders
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Gross Profit (2017 - 2025)

Twist Bioscience (TWST) has disclosed Gross Profit for 6 consecutive years, with $21.9 million as the latest value for Q2 2023.

  • On a quarterly basis, Gross Profit fell 12.91% to $21.9 million in Q2 2023 year-over-year; TTM through Jun 2023 was $90.9 million, a 22.93% increase, with the full-year FY2022 number at $84.2 million, up 62.89% from a year prior.
  • Gross Profit was $21.9 million for Q2 2023 at Twist Bioscience, up from $18.5 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $25.7 million in Q3 2022 to a low of $1.8 million in Q1 2019.
  • A 5-year average of $13.2 million and a median of $14.5 million in 2020 define the central range for Gross Profit.
  • Peak YoY movement for Gross Profit: skyrocketed 1023.84% in 2019, then dropped 12.91% in 2023.
  • Twist Bioscience's Gross Profit stood at $3.4 million in 2019, then surged by 196.53% to $10.0 million in 2020, then soared by 49.63% to $15.0 million in 2021, then skyrocketed by 65.76% to $24.8 million in 2022, then dropped by 11.72% to $21.9 million in 2023.
  • Per Business Quant, the three most recent readings for TWST's Gross Profit are $21.9 million (Q2 2023), $18.5 million (Q1 2023), and $24.8 million (Q4 2022).